Kenneth Borow, MD

Chief Medical Officer

Dr. Ken Borow is a highly experienced physician, clinical trialist, problem solver, and healthcare entrepreneur.  He is a Harvard-trained adult cardiologist, pediatric cardiologist, internist and pediatrician with over 30 years of patient-related care and clinical research.  As a faculty member at Harvard Medical School, Professor of Medicine and Pediatrics at the University of Chicago, and leading expert across multiple therapeutic areas in healthcare, he is the author of more than 130 peer-reviewed publications. In his career, Dr. Borow has helped design and operationalize over 100 development programs for drugs, biologics, medical devices, and combination products.  He has had broad involvement with Data Safety Monitoring Boards (DSMB), Clinical Endpoints Committees (CEC), the US FDA and EMA.

Throughout his career, Dr. Borow has been Director of the Cardiovascular Non-Invasive Imaging Program at the University of Chicago, Head of Clinical Research Operations in the U.S. and Puerto Rico for Merck Research Laboratories, and CEO of a NASDAQ-traded contract research organization (CRO) with operations in 30 countries.  In the latter position, he led the company’s consulting business, was actively involved in the design and conduct of multiple clinical trials and helped build the Company into an internationally recognized provider of quality consulting and clinical operational services.  He holds multiple medical related patents and has been a senior advisor to a myriad of biopharmaceutical and other companies including prominent venture capital firms around the world.

As MediMergent’s Chief Medical Officer, Dr. Borow has been actively involved in study design development and operations as well as driving processes towards more patient centric outcomes.  He has helped develop innovative ways to design and execute hybrid research programs that bridge the gap between real-world evidence and objective immunological biomarkers (including T-cell and B-cell function).
Read More